跳转至内容
Merck
CN

AB1426

抗解偶联蛋白1抗体

Chemicon®, from rabbit

别名:

UCP1

登录 查看组织和合同定价。

选择尺寸

关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
polyclonal
Application:
ELISA
western blot
Species reactivity:
human, rat, mouse
Citations:
17
Technique(s):
ELISA: suitable
western blot: suitable
Uniprot accession no.:
P25874

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

抗解偶联蛋白1抗体, Chemicon®, from rabbit

biological source

rabbit

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

polyclonal

species reactivity

human, rat, mouse

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable
western blot: suitable

NCBI accession no.

NM_021833.3

UniProt accession no.

P25874

shipped in

dry ice

target post-translational modification

unmodified

Quality Level

100

Gene Information

human ... UCP1(7350)

相关类别

Application

ELISA：1：100,000

蛋白质印迹：1:1,000

最佳工作稀释度必须由最终用户进行确定。
研究子类别
离子 & 运输渠道
研究类别
代谢
该抗解偶联蛋白1抗体经验证可用于ELISA和WB检测解偶联蛋白1。

Biochem/physiol Actions

与小鼠、大鼠和人UCP1反应。反应性通过与棕色脂肪组织的纯化UCP的蛋白质印迹验证。与 UCP2没有交叉反应。

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

Immunogen

合成肽，对应于小鼠UCP1氨基酸145-159。(C)SHLHGIKPRYTGTYN

Physical form

形式：纯化
蛋白 A 纯化的兔免疫球蛋白。 液体。缓冲液=100 mM KHPO4，140 mM NaCl，pH 7。 不含防腐剂。

Preparation Note

将未稀释的等分试样在-20°C下保存长达12个月。应避免反复冻/融循环。

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品？  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

RIP140-targeted repression of gene expression in adipocytes.
Christian, M; Kiskinis, E; Debevec, D; Leonardsson, G; White, R; Parker, MG
Molecular and cellular biology null
Jing-Lin Wang et al.
Cell death & disease, 12(1), 111-111 (2021-01-23)
Hepatectomy is an effective therapeutic strategy for many benign and malignant liver diseases, while the complexity of liver anatomy and the difficulty of operation lead to complications after hepatectomy. Among them, post-hepatectomy liver failure (PHLF) is the main factor threatening
Assunta Lombardi et al.
PloS one, 10(2), e0116498-e0116498 (2015-02-07)
3,5-Diiodo-l-thyronine (T2), a thyroid hormone derivative, is capable of increasing energy expenditure, as well as preventing high fat diet-induced overweight and related metabolic dysfunction. Most studies to date on T2 have been carried out on liver and skeletal muscle. Considering
Hongyi Zhou et al.
Journal of lipid research, 56(10), 1912-1925 (2015-08-14)
Mutations in BSCL2/SEIPIN cause Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2), but the mechanisms whereby Bscl2 regulates adipose tissue function are unclear. Here, we generated adipose tissue (mature) Bscl2 knockout (Ad-mKO) mice, in which Bscl2 was specifically ablated in adipocytes of
Kana Oue et al.
The Journal of biological chemistry, 291(8), 4185-4196 (2015-12-27)
Phospholipase C-related catalytically inactive protein (PRIP) was first identified as an inositol 1,4,5-trisphosphate-binding protein, and was later found to be involved in a variety of cellular events, particularly those related to protein phosphatases. We previously reported that Prip knock-out (KO)
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持